Protamine enhances the activity of human recombinant interferon-γ

Journal of Interferon and Cytokine Research

Volumn 16, Issue 7, 1996, Pages 531-536

  Däubener, Walter ^a   Gutsche, Marc ^a   Nockemann, Susanne ^a   Mackenzie, Colin ^a   Seghrouchni, Samira ^a   Hadding, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXYGENASE; PROTAMINE; RECOMBINANT GAMMA INTERFERON;

ANTIGEN EXPRESSION; ARTICLE; CHLAMYDIACEAE; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG POTENTIATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA; TUMOR GROWTH;

CHLAMYDIA; CHLAMYDIACEAE; HUMAN IMMUNODEFICIENCY VIRUS; TOXOPLASMA;

EID: 0029793409     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.531     Document Type: Article

References (23)

1. MOSMAN, T.R., SCHUMACHER, J.H., STREET, N.F., BUDD, R., O'GARRA, A., FONG, T.A.T., BOND, M.W., MOORE, K.W.M., SHER, A., and FIORENTIO, D. (1991). Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 123, 209-229.
2. HUNTER, C.A., SUBAUSTE, C.S., VAN CLEAVE, V.H., and REMINGTON, J.S. (1994). Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: Regulation by Interleukin-10, Interleukin-12 and tumor-necrosis-factor-alpha. Infect. Immun. 62, 2818-2824.
3. JANEWAY, C.A., BOTTOMLY, K., BABICH, J., CONRAD, P., CONZEN, S., JONES, B., KAYE, J., KATZ, M., McVAY, L., MURPHY, D.B., and TITE, J. (1984). Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol. Today 5, 99-105.
4. SUZUKI, Y., ORELLANA, M.A., SCHREIBER, R.D., and REMINGTON, J.S. (1988). Interferon-γ. The major mediator of resistence against Toxoplasma gondii. Science 240, 516-518.
5. OZAKI, Y., EDELSTEIN, M.P., and DUCH, D.S. (1988). Induction of indolamine 2,3-dioxygenase: A mechanism of the antitumor activity of interferon-γ. Proc. Natl. Acad. Sci. USA 85, 1242-1246.
6. FARRAR, M.A., and SCHREIBER, D.D. (1993). The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611.
7. LORTAT-JACOB, H., and GRIMAUD, J.A. (1991). Interferon-γ binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett. 280, 152-154.
8. LORTAT-JACOB, H., KLEINMAN, H.K., and GRIMAUD, J.A. (1991). High-affinity binding of interferon-γ to a basement membrane complex (Matrigel). J. Clin. Invest. 87, 878-883.
9. BERNHELD, M., KOKENYESI, R., KATO, M., HINKES, M.T., SPRING, J., GALLO, R.L., and LOSE, E.J. (1992). Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365-393.
10. KORLIPARA, L.V.P., PLEASS, H.C.C., TAYLOR, R.M.R., PROUD, G., FORSYTHE, J.L.R., and KIRBY, J.A. (1994). Heparin antagonizes the induction of class II MHC molecules by interferon-γ. Transplantation 58, 1426-1429.
11. DAUBENER, W., NOCKEMANN, S., GUTSCHE, M., and HADDING, U. (1995). Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ. Eur. J. Immunol. 25, 688-892.
12. BILZER, T., STAVROU, D., KEIDITSCH, E., BÜRRING, K.F., ANZIL, A.P., and WECHSLER, W. (1991) Morphological-immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch. [A] 418, 281-293.
13. DÄUBENER, W., SEGHROUCHNI ZENNATI, S., WERNET, P., BILZER, T., FISCHER, H.G., and HADDING, U. (1992). Human glioblastoma cell line 86HG39 activates T-cells in an antigen specific major histocompatibility complex class H-dependent manner. J. Neuroimmunol. 41, 21-28.
14. DÄUBENER, W., PILZ, K., SEGHROUCHNI ZENNATI, S., BILZER, T., FISCHER, H.G., and HADDING, U. (1993). Induction of toxoplasmostasis in a human glioblastoma by interferon-γ. J. Neuroimmunol. 43, 31-38.
15. DÄUBENER, W., WANAGAT, N., PILZ, K., SEGHROUCHNI, S., FISCHER, H.G., and HADDING, U. (1994). A new, simple, bioassay for human IFN-γ. J. Immunol. Methods 168, 39-47.
16. DÄUBENER, W., MacKENZIE, C., and HADDING, U., (1995). Establishment of T-helper type1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones. Immunology 86, 79-84.
17. PFEFFERKORN, E.R. (1984). Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81, 908-912.
18. MURRAY, H.W., SZURO-SUDOL, A., WELLNER, D., OCA, M.J., GRANGER, A.M., LIBBY, D.M., ROTHERMEL, C.D., and RUBIN, B.Y. (1989). Role of Tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect. Immun. 57, 845-849.
19. FENG, G.S., and TAYLOR, M.W. (1989). Interferon γ-resistant mutants are defective in the induction of indolamine 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 86, 7144-7148.
20. SIBLEY, D., MESSINA, M., and NIESMAN, I.R. (1994). Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc. Natl. Acad. Sci. USA 91, 5508-5512.
21. LORTAT-JACOB, H., and GRIMAUD, J.A. (1992). Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic but not N-sulfated- groups. Biochim. Biophys. Acta 1117, 126-130.
22. MEDA, L., CASSATELLA, M.A., SZENDREI, G.I., OTVOS, L., BARON, P., VILLALBA, M., FERRARI, D., and ROSSI, F. (1995). Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650.
23. BRUNDEN, K.R., RICHTER-COOK, N.J., CHATURVEDI, N., and FREDERICKSON, R.C.A. (1993). pH-Dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.